Lotemax SM (loteprednol etabonate ophthalmic gel 0.38%) / Bausch Health  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lotemax SM (loteprednol etabonate ophthalmic gel 0.38%) / Bausch Health
NCT04418999: Safety and Efficacy of Intracanalicular Dexamethasone Compared to Loteprednol Etabonate in Patients With Keratoconus

Completed
1
18
US
dexamethasone ophthalmic insert 0.4 mg, for intracanalicular use, Dextenza, Loteprednol Etabonate 0.38% Ophthalmic Gel/Jelly, Lotemax
Illinois College of Optometry
Keratoconus, Dry Eye, Allergy
12/21
12/21

Download Options